DYN
Price
$20.65
Change
-$0.22 (-1.05%)
Updated
Jun 23, 04:05 PM (EDT)
Capitalization
3.45B
37 days until earnings call
Intraday BUY SELL Signals
RCUS
Price
$27.91
Change
+$0.68 (+2.50%)
Updated
Jun 23, 04:16 PM (EDT)
Capitalization
3.42B
50 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DYN vs RCUS

DYN vs RCUS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
DYN vs. RCUS commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYN is a Buy and RCUS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 23, 2026
Stock price -- (DYN: $20.89 vs. RCUS: $27.23)
Brand notoriety: DYN and RCUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DYN: 153% vs. RCUS: 275%
Market capitalization -- DYN: $3.45B vs. RCUS: $3.42B
DYN [@Biotechnology] is valued at $3.45B. RCUS’s [@Biotechnology] market capitalization is $3.42B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYN’s FA Score shows that 1 FA rating(s) are green whileRCUS’s FA Score has 0 green FA rating(s).

  • DYN’s FA Score: 1 green, 4 red.
  • RCUS’s FA Score: 0 green, 5 red.
According to our system of comparison, DYN is a better buy in the long-term than RCUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYN’s TA Score shows that 6 TA indicator(s) are bullish while RCUS’s TA Score has 4 bullish TA indicator(s).

  • DYN’s TA Score: 6 bullish, 3 bearish.
  • RCUS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, DYN is a better buy in the short-term than RCUS.

Price Growth

DYN (@Biotechnology) experienced а +11.53% price change this week, while RCUS (@Biotechnology) price change was +12.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.00%. For the same industry, the average monthly price growth was +3.15%, and the average quarterly price growth was +1992.95%.

Reported Earning Dates

DYN is expected to report earnings on Jul 30, 2026.

RCUS is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Biotechnology (+7.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DYN($3.45B) and RCUS($3.43B) have the same market capitalization . RCUS YTD gains are higher at: 14.268 vs. DYN (6.800). RCUS has higher annual earnings (EBITDA): -350M vs. DYN (-439.22M). DYN has more cash in the bank: 972M vs. RCUS (822M). RCUS has less debt than DYN: RCUS (113M) vs DYN (169M). RCUS has higher revenues than DYN: RCUS (236M) vs DYN (0).
DYNRCUSDYN / RCUS
Capitalization3.45B3.43B101%
EBITDA-439.22M-350M125%
Gain YTD6.80014.26848%
P/E RatioN/AN/A-
Revenue0236M-
Total Cash972M822M118%
Total Debt169M113M150%
FUNDAMENTALS RATINGS
RCUS: Fundamental Ratings
RCUS
OUTLOOK RATING
1..100
37
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
94
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DYNRCUS
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 16 days ago
86%
Bearish Trend 21 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
DYN
Daily Signal:
Gain/Loss:
RCUS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SOXY114.391.99
+1.77%
YieldMax Target 12 Smcndctr Opt Inc ETF
MNZL61.070.25
+0.42%
Manzil Russell Halal USA Broad MarketETF
KOCT37.130.10
+0.26%
Innovator US Small Cap Pwr Buff ETF™ Oct
SUSA153.14-0.11
-0.07%
iShares ESG Optimized MSCI USA ETF
NBOS28.10-0.03
-0.11%
Neuberger Option Strategy ETF

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with RNA. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
+5.51%
RNA - DYN
64%
Loosely correlated
+2.21%
RCUS - DYN
46%
Loosely correlated
+12.01%
VYGR - DYN
45%
Loosely correlated
N/A
XNCR - DYN
44%
Loosely correlated
+10.84%
NTLA - DYN
44%
Loosely correlated
+0.51%
More

RCUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with XNCR. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCUS
1D Price
Change %
RCUS100%
+12.01%
XNCR - RCUS
50%
Loosely correlated
+10.84%
VIR - RCUS
50%
Loosely correlated
+4.48%
DYN - RCUS
46%
Loosely correlated
+5.51%
KURA - RCUS
44%
Loosely correlated
+4.33%
NRIX - RCUS
44%
Loosely correlated
+6.27%
More